Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05846-5Source: DataRank Database

Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy is a research paper published in Breast Cancer Research and Treatment (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 0.30)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Caroline A. Nebhan ORCID,Jinming Yang ORCID,Lauren S. Starnes ORCID,Chi Yan ORCID,Anna E. Vilgelm ORCID

Live enrichment

PubMed:32767201 PMC:PMC7606736 OpenAlex:https://openalex.org/W3047645321

National Cancer Institute

Grant: CA34590

National Cancer Institute

Grant: P50CA098131

National Cancer Institute

Grant: 5T32CA009592 30

Breast Cancer Research Foundation

Grant: IIDRP-16-001

U.S. Department of Veterans Affairs

Grant: 5101BX000196-04

National Institutes of Health

Grant: CA90625

Vanderbilt University

Grant: P30 CA68485

NCI NIH HHS

Grant: R37 CA233770

NCI NIH HHS

Grant: T32 CA217834

NCI NIH HHS

Grant: F32 CA254070

BLRD VA

Grant: I01 BX002301

NCI NIH HHS

Grant: K12 CA090625

NCI NIH HHS

Grant: P30 CA068485

BLRD VA

Grant: IK6 BX005225

NCI NIH HHS

Grant: R01 CA243326

NCI NIH HHS

Grant: T32 CA009592

NCI NIH HHS

Grant: R01 CA034590

National Institutes of Health

Grant: 1T32CA217834-01A1

VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)

National Institutes of Health

Grant: 3T32CA009592-20S1

Multidisciplinary Basic Research Training in Cancer

National Institutes of Health

Grant: 3P30CA068485-04S3

Core--Biostatistics

National Institutes of Health

Grant: 3P50CA098131-15S1

SPORE in Breast Cancer

National Institutes of Health

Grant: 5R01CA034590-29

Chemokine Receptor Studies: Defining the Dynamics of the Chemosynapse

National Institutes of Health

Grant: 2K12CA090625-06

Vanderbilt Clinical Oncology Research Career Development Program

FWCI

0.30

Citation Percentile

0.5%

Citation Trend

2021

2024

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7606736

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-020-05846-5.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-020-05846-5/fulltext.html

journalhttps://doi.org/10.1007/s10549-020-05846-5

Fields of Study

PI3K/AKT/mTOR signaling in cancerCancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune Response0301 basic medicine0303 health sciences03 medical and health sciencesBreast NeoplasmsFemaleHumansImmunotherapyLeukocytesPhosphatidylinositol 3-KinasesProtein Kinase Inhibitors

MeSH Terms

Breast NeoplasmsFemaleHumansImmunotherapyLeukocytesPhosphatidylinositol 3-KinasesProtein Kinase Inhibitors

Keywords

MedicineImmune systemImmunotherapyPI3K/AKT/mTOR pathwayMetastatic breast cancerBreast cancerPopulationCytotoxic T cellCancerImmunologyT cellOncologyInternal medicineBiologySignal transductionBreastLeukocytePI3KMetastaticPhosphatidylinositol 3-KinasesLeukocytesHumansBreast NeoplasmsFemaleProtein Kinase Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy

FAIR Checklist

Authors (11)

Funding (23 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)